Fox NewsHealth
Drug linked to lower risk in advanced breast cancer trial
A phase three trial published in the Journal of the American Medical Association found trastuzumab rezetecan was associated with a 73 percent lower risk of cancer progression or death than chemotherapy in people with advanced breast cancer.
This card is an AI-assisted summary of reporting published by Fox News. Read the original report before relying on it for medical, legal, financial, safety, or emergency decisions.